Institutional Ownership
Theravance Biopharma Inc
CUSIP G8807B106COMTBPHQ1 2026
13D / 13G Filings
53
Schedule 13D/13G on record
Beneficial Filers
17
Distinct reporting persons
Largest Stake
19.5%
Max % of class reported
Institutional Holders
165
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
53 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Newtyn Management, LLC | 13G/A | 8.5% | 4.30M | SEC |
| 2 | Apr 30, 2025 | Blackrock, Inc. | 13G/A | 6.5% | 3.24M | SEC |
| 3 | Feb 14, 2025 | Newtyn Management, LLC | 13G/A | 9.7% | 4.76M | SEC |
| 4 | Nov 14, 2024 | Madison Avenue Partners, LP | 13G/A | 19.4% | 9.51M | SEC |
| 5 | Nov 12, 2024 | Vanguard Group Inc | 13G/A | 4.2% | 2.05M | SEC |
| 6 | Nov 4, 2024 | Vanguard Group Inc | 13G/A | 4.2% | 2.05M | SEC |
| 7 | Nov 4, 2024 | Vanguard Group Inc | 13G/A | 4.2% | 2.05M | SEC |
| 8 | Sep 9, 2024 | Baupost Group LLC/Ma | 13G/A | — | — | SEC |
| 9 | Aug 16, 2024 | Newtyn Management, LLC | 13G | 8.4% | 4.10M | SEC |
| 10 | Aug 9, 2024 | Baupost Group LLC/Ma | 13G/A | 6.1% | 2.98M | SEC |
43 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Theravance Biopharma Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Madison Avenue Partners, LP | 9.51M | $154.37M |
| 2 | Weiss Asset Management LP | 7.46M | $121.03M |
| 3 | Newtyn Management, LLC | 4.84M | $78.58M |
| 4 | Blackrock, Inc. | 4.30M | $69.73M |
| 5 | Irenic Capital Management LP | 2.76M | $44.81M |
| 6 | State Street Corp | 1.30M | $21.06M |
| 7 | Two Sigma Investments, LP | 1.26M | $20.43M |
| 8 | Geode Capital Management, LLC | 1.14M | $18.46M |
| 9 | Dimensional Fund Advisors LP | 983.6K | $15.96M |
| 10 | D. E. Shaw & Co., Inc. | 954.0K | $15.48M |